Translate
Shanghai Fosun Pharmaceutical Group Co Ltd
About
Shanghai Fosun Pharmaceutical Group Co Ltd (SHG:600196) — investor relations, events, news, and company updates on 6ix.
Latest News
Dec 9 2025
Fosun Pharma's Subsidiary Yao Pharma and Pfizer Enter into Exclusive Collaboration and License Agreement
Oct 28 2025
Fosun Pharma Announces 2025Q3 Financial Results
Aug 26 2025
Fosun Pharma Announces 2025 Interim Results
Aug 12 2025
Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million
Jun 16 2025
Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology
Financials
Revenue
CN¥41.66 B
Market Cap
CN¥71.3 B
P/E Ratio
21.02
EPS
1.27
Dividend Yield
1.44%